These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19375042)

  • 1. [HIV-HCV co-infection: where are we now?].
    Piroth L
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S94-6. PubMed ID: 19375042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S118-9. PubMed ID: 19375040
    [No Abstract]   [Full Text] [Related]  

  • 4. [ANRS HC 02 RIBAVIC: histo-pathological impact].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S106-9. PubMed ID: 19375037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol].
    Pivert A; Payan C; Lunel F;
    Pathol Biol (Paris); 2004 Nov; 52(9):522-8. PubMed ID: 15531116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANRS HC 02 RIBAVIC: summary and recommandations].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S104-5. PubMed ID: 19375036
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
    Sterling RK; Sulkowski MS
    Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hepatitis C virus infection in patients with concurrent human immunodeficiency virus infection].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3604-8. PubMed ID: 17069721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
    Franchini M
    Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
    J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.
    Kang W; Tong HI; Sun Y; Lu Y
    Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):247-66. PubMed ID: 24450362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.
    Pivert A; Payan C; Morand P; Fafi-Kremer S; Deshayes J; Carrat F; Pol S; Cacoub P; Perronne C; Lunel F
    J Clin Microbiol; 2006 Feb; 44(2):417-22. PubMed ID: 16455894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients].
    Francisci D; Valente M; Di Candilo F; Sfara C; Conte ME; Canovari B; Baldelli F; Stagni G
    Recenti Prog Med; 2004 Nov; 95(11):521-4. PubMed ID: 15598089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
    Neumann A; Polis M; Rozenberg L; Jackson J; Reitano K; McLaughlin M; Koratich C; Dewar R; Masur H; Haagmans B; Kottilil S
    AIDS; 2007 Sep; 21(14):1855-65. PubMed ID: 17721093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
    Halfon P; Pénaranda G; Cacoub P
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S113-7. PubMed ID: 19375039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis C in HIV-infected patients].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S97-S103. PubMed ID: 19375043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.